Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
osi-930 | vascular endothelial growth factor receptor 1 | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.21 | investigational | inhibitor |
osi-930 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.27 | phase 1 | inhibitor |
osi-930 | vascular endothelial growth factor receptor 2 | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.27 | phase 1 | unknown |
osi-930 | tyrosine-protein kinase kit | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.38 | phase 1 | unknown |
osi-930 | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.38 | investigational | inhibitor |
osi-930 | tyrosine-protein kinase kit | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.38 | phase 1 | inhibitor |
osi-930 | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.38 | investigational | unknown |
click here to return to the previous page |